Skip to main content
. 2019 Jun 4;14(6):e0217805. doi: 10.1371/journal.pone.0217805

Table 2. Studies evaluating rate of exudation in eyes with subclinical CNV.

Study Eyes with Subclinical CNV Eyes Progressed to Exudative AMD Follow up period
Dias et al. (2017) 23 5 (21.7%) 12 months
Capuano et al. (2017) 19 (GA only) 5 (26.3%) 6 months
Carnevali et al. (2018) 15 1 (6.67%) 12 months
Yanagi et al. (2018) 18 (includes PCV) 4 (estimated 18.1% annually) >6 months
Our study 5 1 (20.0%) 12 months